Global Drug Delivery Technology Market - Technologies, Market share and Industry Forecast to 2024

  • ID: 4585965
  • Report
  • Region: Global
  • 240 Pages
  • Occams Business Research and Consulting
1 of 4

FEATURED COMPANIES

  • 3M Company (U.S.)
  • Bayer AG (Germany)
  • Glaxosmithkline Plc (Uk)
  • Merck & Co., Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • MORE

Drug delivery technology deals with release and transfer of a pharmaceutical drug to the body to achieve the health benefits. Global drug delivery technology market is expected to rise with the CAGR of about 7.1% during forecast period 2017-2024. Growth in biologics industry contributes towards the growth of global drug delivery technology market during forecast period. However, side effects of drugs coupled with risk associated with needle stick injuries and product recalls and failures are some of the major factors restraining the growth of global drug delivery technology market during the forecast period. Increasing demand for generic drugs and biosimilars is one of the major opportunities whereas patent cliff and expiry acts as one of the challenges for global drug delivery technology market.

Geographically, global drug delivery technology market report has been segmented in North America, Asia Pacific, Europe, and Rest of the World. North America is expected to dominate global drug delivery technology market during the forecast period due to factors such as high prevalence of chronic diseases such as cancer, cardio vascular diseases, diabetes, respiratory diseases, ongoing technological advancements in drug delivery technology, etc. However, Asia Pacific is expected to emerge as the fastest growing region in global drug delivery technology market during the forecast period due to investments by major companies in research and development, etc.

The growth in global drug delivery technology market is also influenced by the presence of major players such as Bayer AG (Germany), Glaxosmithkline PLC (United Kingdom), Merck & Co., Inc. (United States), Novartis AG (Switzerland), Pfizer, Inc. (United States), etc. In order to gain competitive advantage, the major players of global drug delivery technology market are adopting various strategies such as mergers & acquisitions, product launch, strategic partnership, collaboration, joint ventures, investment, strategic expansion, funding etc. during the forecast period.

The report on global drug delivery technology market is segmented on the basis of route of administration and facility of use. Route of administration segment of global drug delivery technology market is further sub divided as oral drug delivery, pulmonary drug delivery, injectable drug delivery, ocular drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery. Also, the facility of use segment of global drug delivery technology market is sub segmented as hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers and other facilities of use. Topical drug delivery is expected to be the fastest growing segment in global drug delivery technology market during the forecast period due to its advantages such as convenience, ease of use, noninvasiveness, etc. 

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company (U.S.)
  • Bayer AG (Germany)
  • Glaxosmithkline Plc (Uk)
  • Merck & Co., Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Drug Delivery Technology Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Growth In Biologics Industry
3.1.2. Increasing Prevalence Of Chronic Diseases
3.1.3. Technological Advancements With Launch Of New Products
3.1.4. Increasing Demand For Effective Delivery Mechanisms Of Novel Biopharmaceuticals
3.2. Market Restraints
3.2.1. Product Recalls And Failures
3.2.2. Side Effects Of Drugs Coupled With Risk Associated With Needlestick Injuries
3.3. Market Opportunities
3.3.1. Increasing Demand For Generic Drugs And Biosimilars
3.3.2. Increasing Focus On Home Care And Self-Administration
3.4.   Market Challenges
3.4.1. Patent Cliff And Expiry
3.4.2. Pricing Pressure

4. Global Drug Delivery Technology Market By Route Of Administration
4.1. Market Definition And Scope
4.2. Decision Support Database & Estimation Methodology
4.3. Comparative Analysis Across Market Segments
4.4. Opportunity Matrix
4.5. Market Segmentation
4.5.1. Global Oral Drug Delivery Market
4.5.1.1. Adoption Scenario & Market Determinants
4.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.1.3. Key Players & Key Products
4.5.1.4. Key Conclusions
4.5.1.5. Market Sub-Segments
4.5.1.5.1. Solid Oral Drugs
4.5.1.5.1.1. Capsules
4.5.1.5.1.2. Pills
4.5.1.5.1.3. Powders
4.5.1.5.1.4. Tablets
4.5.1.5.2. Liquid Oral Drugs
4.5.1.5.2.1. Solutions
4.5.1.5.2.2. Syrups
4.5.1.5.3. Semi-Solid Oral Drugs
4.5.1.5.3.1. Elixirs
4.5.1.5.3.2. Emulsions
4.5.1.5.3.3. Gels
4.5.2. Global Pulmonary Drug Delivery Market
4.5.2.1. Adoption Scenario & Market Determinants
4.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.2.3. Key Players & Key Products
4.5.2.4. Key Conclusions
4.5.2.5. Market Sub-Segments
4.5.2.5.1. Formulations
4.5.2.5.2. Devices
4.5.2.5.2.1. Metered Dose Inhalers
4.5.2.5.2.2. Dry Powder Inhalers
4.5.2.5.2.3. Nebulizers
4.5.2.5.2.3.1. Jet Nebulizers
4.5.2.5.2.3.2. Soft Mist Nebulizers
4.5.2.5.2.3.3. Ultrasonic Nebulizers
4.5.3. Global Injectable Drug Delivery Market
4.5.3.1. Adoption Scenario & Market Determinants
4.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.3.3. Key Players & Key Products
4.5.3.4. Key Conclusions
4.5.3.5. Market Sub-Segments
4.5.3.5.1. Devices
4.5.3.5.1.1. Conventional Injection Devices
4.5.3.5.1.1.1. By Material
4.5.3.5.1.1.2. Glass
4.5.3.5.1.1.3. Plastic
4.5.3.5.1.1.4. By Product
4.5.3.5.1.1.4.1. Fillable Syringes
4.5.3.5.1.1.4.2. Prefilled Syringes
4.5.3.5.1.1.5. By Usability
4.5.3.5.1.1.5.1. Disposable Syringes
4.5.3.5.1.1.5.2. Reusable Syringes
4.5.3.5.1.2. Self-Injection Devices
4.5.3.5.1.2.1. Autoinjectors
4.5.3.5.1.2.2. Needle-Free Injectors
4.5.3.5.1.2.3. Pen Injectors
4.5.3.5.1.2.4. Wearable Injectors
4.5.3.5.1.3. Other Injector Devices
4.5.3.5.2. Formulations
4.5.3.5.2.1. Conventional Drug Delivery
4.5.3.5.2.2. Long-Acting Injection Formulations
4.5.3.5.2.3. Novel Drug Delivery Formulations
4.5.4. Global Ocular Drug Delivery Market
4.5.4.1. Adoption Scenario & Market Determinants
4.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.4.3. Key Players & Key Products
4.5.4.4. Key Conclusions
4.5.4.5. Market Sub-Segments
4.5.4.5.1. Formulations
4.5.4.5.1.1. Liquid Formulations
4.5.4.5.1.1.1. Eye Drops
4.5.4.5.1.1.2. Liquid Sprays
4.5.4.5.1.2. Semi-Solid Formulations
4.5.4.5.1.2.1. Eye Ointments
4.5.4.5.1.2.2. Gels
4.5.4.5.2. Ocular Devices
4.5.4.5.2.1. Drug-Coated Contact Lenses
4.5.4.5.2.2. Ocular Inserts
4.5.5. Global Nasal Drug Delivery Market
4.5.5.1. Adoption Scenario & Market Determinants
4.5.5.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.5.3. Key Players & Key Products
4.5.5.4. Key Conclusions
4.5.5.5. Market Sub-Segments
4.5.5.5.1. Nasal Drops
4.5.5.5.2. Nasal Gels
4.5.5.5.3. Nasal Powders
4.5.5.5.4. Nasal Sprays
4.5.6. Global Topical Drug Delivery Market
4.5.6.1. Adoption Scenario & Market Determinants
4.5.6.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.6.3. Key Players & Key Products
4.5.6.4. Key Conclusions
4.5.6.5. Market Sub-Segments
4.5.6.5.1. Formulations
4.5.6.5.1.1. Liquid Topical Drug Delivery
4.5.6.5.1.1.1. Solutions
4.5.6.5.1.1.2. Suspensions
4.5.6.5.1.2. Semi-Solid Topical Drug Delivery
4.5.6.5.1.2.1. Creams
4.5.6.5.1.2.2. Gels
4.5.6.5.1.2.3. Lotions
4.5.6.5.1.2.4. Ointments
4.5.6.5.1.2.5. Pastes
4.5.6.5.1.3. Solid Topical Drug Delivery
4.5.6.5.1.3.1. Powders
4.5.6.5.1.3.2. Suppositories
4.5.6.5.2. Devices (Transdermal Drug Delivery)
4.5.6.5.2.1. Transdermal Gels
4.5.6.5.2.2. Transdermal Patches
4.5.7. Global Implantable Drug Delivery Market
4.5.7.1. Adoption Scenario & Market Determinants
4.5.7.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.7.3. Key Players & Key Products
4.5.7.4. Key Conclusions
4.5.7.5. Market Sub-Segments
4.5.7.5.1. Active Implantable Drug Delivery
4.5.7.5.2. Passive Implantable Drug Delivery
4.5.8. Global Transmucosal Drug Delivery Market
4.5.8.1. Adoption Scenario & Market Determinants
4.5.8.2. Market Estimations And Forecasts 2015-2024 ($ Million)
4.5.8.3. Key Players & Key Products
4.5.8.4. Key Conclusions
4.5.8.5. Market Sub-Segments
4.5.8.5.1. Oral Transmucosal Drug Delivery
4.5.8.5.1.1. Buccal Drug Delivery
4.5.8.5.1.2. Sublingual Drug Delivery
4.5.8.5.2. Other Transmucosal Drug Delivery
4.5.8.5.2.1. Rectal Transmucosal Drug Delivery
4.5.8.5.2.2. Vaginal Transmucosal Drug Delivery

5. Global Drug Delivery Technology Market By Facility Of Use
5.1. Market Definition And Scope
5.2. Decision Support Database & Estimation Methodology
5.3. Comparative Analysis Across Market Segments
5.4. Opportunity Matrix
5.5. Market Segmentation
5.5.1. Global Hospitals Market
5.5.1.1. Adoption Scenario & Market Determinants
5.5.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.1.3. Key Players & Key Products
5.5.1.4. Key Conclusions
5.5.2. Global Ambulatory Surgical Centers/Clinics Market
5.5.2.1. Adoption Scenario & Market Determinants
5.5.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.2.3. Key Players & Key Products
5.5.2.4. Key Conclusions
5.5.3. Global Home Care Settings Market
5.5.3.1. Adoption Scenario & Market Determinants
5.5.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.3.3. Key Players & Key Products
5.5.3.4. Key Conclusions
5.5.4. Global Diagnostic Centers Market
5.5.4.1. Adoption Scenario & Market Determinants
5.5.4.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.4.3. Key Players & Key Products
5.5.4.4. Key Conclusions
5.5.5. Global Other Facilities Of Use Market
5.5.5.1. Adoption Scenario & Market Determinants
5.5.5.2. Market Estimations And Forecasts 2015-2024 ($ Million)
5.5.5.3. Key Players & Key Products
5.5.5.4. Key Conclusions

6. Global Drug Delivery Technology Market By  Stakeholders
6.1. Market Definition And Scope
6.2. Decision Support Database & Estimation Methodology
6.3. Market Segmentation 
6.3.1. Global Raw Material Supplier Market
6.3.1.1. Adoption Scenario & Market Determinants
6.3.1.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.3.2. Global Manufacturer Market
6.3.2.1. Adoption Scenario & Market Determinants
6.3.2.2. Market Estimations And Forecasts 2015-2024 ($ Million)
6.3.3. Global Distributor And Logistics Market
6.3.3.1. Adoption Scenario & Market Determinants
6.3.3.2. Market Estimations And Forecasts 2015-2024 ($ Million)

7. Competitive Landscape
7.1. Key Strategies
7.1.1. List Of Mergers And Acquisition
7.1.2. List Of Joint Ventures
7.1.3. List Of Product Launches
7.1.4. List Of Partnerships

8. Geographic Analysis
8.1. Decision Support Database & Estimation Methodology
8.2. Comparative Analysis Across Market Segments
8.3. Opportunity Matrix
8.4.  Global Drug Delivery Technology Market By Region 2015-2024 
8.4.1. North America
8.4.1.1. Industry Analysis 2015-2024 ($ Million)
8.4.1.2. Top Country Analysis
8.4.1.2.1. U.S.
8.4.1.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.1.2.1.2. Key Players & Key Products
8.4.1.2.1.3. Key Conclusions
8.4.1.2.2. Canada
8.4.1.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.1.2.2.2. Key Players & Key Products
8.4.1.2.2.3. Key Conclusions
8.4.2. Europe
8.4.2.1. Industry Analysis 2015-2024 ($ Million)
8.4.2.2. Top Country Analysis
8.4.2.2.1. UK
8.4.2.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.2.2.1.2. Key Players & Key Products
8.4.2.2.1.3. Key Conclusions
8.4.2.2.2. France
8.4.2.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.2.2.2.2. Key Players & Key Products
8.4.2.2.2.3. Key Conclusions
8.4.2.2.3. Germany
8.4.2.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.2.2.3.2. Key Players & Key Products
8.4.2.2.3.3. Key Conclusions
8.4.2.2.4. Spain
8.4.2.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.2.2.4.2. Key Players & Key Products
8.4.2.2.4.3. Key Conclusions
8.4.2.2.5. Rest Of Europe
8.4.2.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.2.2.5.2. Key  Players & Key Products
8.4.2.2.5.3. Key Conclusions
8.4.3. Asia Pacific
8.4.3.1. Industry Analysis 2015-2024 ($ Million)
8.4.3.2. Top Country Analysis
8.4.3.2.1. China
8.4.3.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.3.2.1.2. Key Players & Key Products
8.4.3.2.1.3. Key Conclusions
8.4.3.2.2. India
8.4.3.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.3.2.2.2. Key Players & Key Products
8.4.3.2.2.3. Key Conclusions
8.4.3.2.3. Japan
8.4.3.2.3.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.3.2.3.2. Key Players & Key Products
8.4.3.2.3.3. Key Conclusions
8.4.3.2.4. Australia
8.4.3.2.4.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.3.2.4.2. Key  Players & Key Products
8.4.3.2.4.3. Key Conclusions
8.4.3.2.5. Rest Of Asia Pacific
8.4.3.2.5.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.3.2.5.2. Key  Players & Key Products
8.4.3.2.5.3. Key Conclusions
8.4.4. Row
8.4.4.1. Industry Analysis 2015-2024 ($ Million)
8.4.4.2. Top Country Analysis
8.4.4.2.1. Latin America
8.4.4.2.1.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.4.2.1.2. Key Players & Key Products
8.4.4.2.1.3. Key Conclusions
8.4.4.2.2. Middle East & Africa
8.4.4.2.2.1. Market Estimations And Forecasts 2015-2024 ($ Million)
8.4.4.2.2.2. Key Players & Key Products
8.4.4.2.2.3. Key Conclusions

9. Company Profiles
9.1. 3M Company (U.S.)
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Initiatives
9.1.4. Scot Analysis
9.1.5. Strategic Analysis
9.2. Alkermes (Republic Of Ireland)
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Initiatives
9.2.4. Scot Analysis
9.2.5. Strategic Analysis
9.3. Antares Pharma, Inc. (U.S.)
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Strategic Initiatives
9.3.4. Scot Analysis
9.3.5. Strategic Analysis
9.4. Bayer AG (Germany)
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Strategic Initiatives
9.4.4. Scot Analysis
9.4.5. Strategic Analysis
9.5. Becton, Dickinson And Company (U.S.)
9.5.1. Overview
9.5.2. Product Portfolio
9.5.3. Strategic Initiatives
9.5.4. Scot Analysis
9.5.5. Strategic Analysis
9.6. F. Hoffmann-La Roche Ltd. (Switzerland)
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Strategic Initiatives
9.6.4. Scot Analysis
9.6.5. Strategic Analysis
9.7. Generex Biotechnology (Canada)
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Strategic Initiatives
9.7.4. Scot Analysis
9.7.5. Strategic Analysis
9.8. Glaxosmithkline Plc (UK)
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Strategic Initiatives
9.8.4. Scot Analysis
9.8.5. Strategic Analysis
9.9. Johnson & Johnson Services, Inc. (U.S.)
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Strategic Initiatives
9.9.4. Scot Analysis
9.9.5. Strategic Analysis
9.10. Merck & Co., Inc. (U.S.)
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Strategic Initiatives
9.10.4. Scot Analysis
9.10.5. Strategic Analysis
9.11. Novartis AG (Switzerland)
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Strategic Initiatives
9.11.4. Scot Analysis
9.11.5. Strategic Analysis
9.12. Pfizer, Inc. (U.S.)
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Strategic Initiatives
9.12.4. Scot Analysis
9.12.5. Strategic Analysis
9.13. Psivida Corppration (U.S.)
9.13.1. Overview 
9.13.2. Product Portfolio
9.13.3. Strategic Initiatives
9.13.4. Scot Analysis
9.13.5. Strategic Analysis
9.14. Sanofi S.A. (France)
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Strategic Initiatives
9.14.4. Scot Analysis
9.14.5. Strategic Analysis
9.15. Vectura Group Plc (UK)
9.15.1. Overview
9.15.2. Product Portfolio
9.15.3. Strategic Initiatives
9.15.4. Scot Analysis
9.15.5. Strategic Analysis

List Of Tables
1. Global Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
2. Global Oral Drug Delivery Market By Geography 2015-2024 ($ Million)
3. Global Drug Delivery Technology Market By Oral Drug Delivery 2015-2024 ($ Million)
4. Global Oral Drug Delivery Market By Solid Oral Drugs 2015-2024 ($ Million)
5. Global Oral Drug Delivery Market By Liquid Oral Drugs 2015-2024 ($ Million)
6. Global Oral Drug Delivery Market By Semi-Solid Oral Drugs 2015-2024 ($ Million)
7. Global Pulmonary Drug Delivery Market By Geography 2015-2024 ($ Million)
8. Global Drug Delivery Technology Market By Pulmonary Drug Delivery 2015-2024 ($ Million)
9. Global Pulmonary Drug Delivery Market By Devices 2015-2024 ($ Million)
10. Global Pulmonary Drug Delivery Devices Market By Nebulizers 2015-2024 ($ Million)
11. Global Injectable Drug Delivery Market By Geography 2015-2024 ($ Million)
12. Global Drug Delivery Technology Market By Injectable Drug Delivery 2015-2024 ($ Million)
13. Global Injectable Drug Delivery Market By Devices 2015-2024 ($ Million)
14. Global Injectable Drug Delivery Devices Market By Conventional Injection Devices 2015-2024 ($ Million)
15. Global Conventional Injection Devices Market By Product 2015-2024 ($ Million)
16. Global Conventional Injection Devices Market By Usability 2015-2024 ($ Million)
17. Global Injectable Drug Delivery Devices Market By Self-Injection Devices 2015-2024 ($ Million)
18. Global Injectable Drug Delivery Market By Formulations 2015-2024 ($ Million)
19. Global Ocular Drug Delivery Market By Geography 2015-2024 ($ Million)
20. Global Drug Delivery Technology Market By Ocular Drug Delivery 2015-2024 ($ Million)
21. Global Ocular Drug Delivery Market By Formulations 2015-2024 ($ Million)
22. Global Ocular Drug Delivery Formulations Market By Liquid Formulations 2015-2024 ($ Million)
23. Global Ocular Drug Delivery Formulations Market By Semi-Solid Formulations 2015-2024 ($ Million)
24. Global Ocular Drug Delivery Market By Ocular Devices 2015-2024 ($ Million)
25. Global Nasal Drug Delivery Market By Geography 2015-2024 ($ Million)
26. Global Drug Delivery Technology Market By Nasal Drug Delivery 2015-2024 ($ Million)
27. Global Topical Drug Delivery Market By Geography 2015-2024 ($ Million)
28. Global Drug Delivery Technology Market By Topical Drug Delivery 2015-2024 ($ Million)
29. Global Topical Drug Delivery Market By Formulations 2015-2024 ($ Million)
30. Global Topical Drug Delivery Formulations Market By Liquid Topical Drug Delivery 2015-2024 ($ Million)
31. Global Topical Drug Delivery Formulations Market By Semi-Solid Topical Drug Delivery 2015-2024 ($ Million)
32. Global Topical Drug Delivery Formulations Market By Solid Topical Drug Delivery 2015-2024 ($ Million)
33. Global Topical Drug Delivery Market By Devices 2015-2024 ($ Million)
34. Global Implantable Drug Delivery Market By Geography 2015-2024 ($ Million)
35. Global Drug Delivery Technology Market By Implantable Drug Delivery 2015-2024 ($ Million)
36. Global Transmucosal Drug Delivery Market By Geography 2015-2024 ($ Million)
37. Global Drug Delivery Technology Market By Transmucosal Drug Delivery 2015-2024 ($ Million)
38. Global Transmucosal Drug Delivery Market By Oral Transmucosal Drug Delivery 2015-2024 ($ Million)
39. Global Transmucosal Drug Delivery Market By Other Transmucosal Drug Delivery 2015-2024 ($ Million)
40. Global Drug Delivery Technology Market By Facility Of Use 2015-2024 ($ Million)
41. Global Hospitals Market By Geography 2015-2024 ($ Million)
42. Global Ambulatory Surgical Centers/Clinics Market By Geography 2015-2024 ($ Million)
43. Global Home Care Settings Market By Geography 2015-2024 ($ Million)
44. Global Diagnostic Centers Market By Geography 2015-2024 ($ Million)
45. Global Other Facilities Of Use Market By Geography 2015-2024 ($ Million)
46. Global Drug Delivery Technology Market By  Stakeholders 2015-2024 ($ Million)
47. North America Drug Delivery Technology Market 2015-2024 ($ Million)
48. Europe Drug Delivery Technology Market 2015-2024 ($ Million)
49. Asia Pacific Drug Delivery Technology Market 2015-2024 ($ Million)
50. Rest Of The World Drug Delivery Technology Market 2015-2024 ($ Million)
51. North America Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
52. Europe Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
53. Asia Pacific Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
54. Rest Of The World Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
55. North America Drug Delivery Technology Market By Facility Of Use 2015-2024 ($ Million)
56. Europe Drug Delivery Technology Market By Facility Of Use 2015-2024 ($ Million)
57. Asia Pacific Drug Delivery Technology Market By Facility Of Use 2015-2024 ($ Million)
58. Rest Of The World Drug Delivery Technology Market By Facility Of Use 2015-2024 ($ Million)
59. United States Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
60. Canada Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
61. UK Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
62. France Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
63. Germany Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
64. Spain Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
65. ROE Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
66. China Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
67. India Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
68. Japan Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
69. Australia Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
70. Roapac Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
71. Latin America Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)
72. MENA Drug Delivery Technology Market By Route Of Administration 2015-2024 ($ Million)

List Of Figures
1. Global Oral Drug Delivery Market 2015-2024 ($ Million)
2. Global Pulmonary Drug Delivery Market 2015-2024 ($ Million)
3. Global Injectable Drug Delivery Market 2015-2024 ($ Million)
4. Global Ocular Drug Delivery Market 2015-2024 ($ Million)
5. Global Nasal Drug Delivery Market 2015-2024 ($ Million)
6. Global Topical Drug Delivery Market 2015-2024 ($ Million)
7. Global Implantable Drug Delivery Market 2015-2024 ($ Million)
8. Global Transmucosal Drug Delivery Market 2015-2024 ($ Million)
9. Global Hospitals Market 2015-2024 ($ Million)
10. Global Ambulatory Surgical Centers/Clinics Market 2015-2024 ($ Million)
11. Global Home Care Settings Market 2015-2024 ($ Million)
12. Global Diagnostic Centers Market 2015-2024 ($ Million)
13. Global Other Facilities Of Use Market 2015-2024 ($ Million)
15. United States (U.S.) Drug Delivery Technology Market 2015-2024 ($ Million)
16. Canada Drug Delivery Technology Market 2015-2024 ($ Million)
17. United Kingdom (UK) Drug Delivery Technology Market 2015-2024 ($ Million)
18. France Drug Delivery Technology Market 2015-2024 ($ Million)
19. Germany Drug Delivery Technology Market 2015-2024 ($ Million)
20. Spain Drug Delivery Technology Market 2015-2024 ($ Million)
21. ROE Drug Delivery Technology Market 2015-2024 ($ Million)
22. India Drug Delivery Technology Market 2015-2024 ($ Million)
23. China Drug Delivery Technology Market 2015-2024 ($ Million)
24. Japan Drug Delivery Technology Market 2015-2024 ($ Million)
25. Australia Drug Delivery Technology Market 2015-2024 ($ Million)
26. Roapac Drug Delivery Technology Market 2015-2024 ($ Million)
27. Latin America Drug Delivery Technology Market 2015-2024 ($ Million)
28. MENA Drug Delivery Technology Market 2015-2024 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company (U.S.)
  • Alkermes (Republic Of Ireland)
  • Antares Pharma, Inc. (U.S.)
  • Bayer AG (Germany)
  • Becton, Dickinson And Company (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Generex Biotechnology (Canada)
  • Glaxosmithkline Plc (Uk)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • Psivida Corppration (U.S.)
  • Sanofi S.A. (France)
  • Vectura Group Plc (Uk)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll